Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article matching "cardiovascular"

ResearchPUBMEDMar 26

In silico Analysis of CHD4 Mutations Reveals Domain-Specific Impacts on Cardiovascular Disorders Among Patients With Rare Diseases.

Scientists studied how different mutations in the CHD4 gene affect the heart and blood vessels in patients with rare diseases. CHD4 is a protein that helps control how genes are turned on and off in cells. By using computer analysis, researchers found that mutations in different parts of this protein cause different types of heart and vessel problems, which could help doctors better understand and classify these genetic conditions.

WHY IT MATTERSThis research provides a framework for doctors to predict how specific CHD4 mutations will affect individual patients' hearts and blood vessels, potentially improving diagnosis and treatment planning for rare conditions like Sifrim-Hitz-Weiss syndrome and moyamoya angiopathy.
💬 Ask your doctorSifrim-Hitz-Weiss syndromeMoyamoya angiopathyChildhood idiopathic epilepsy with sinus arrhythmiaRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases